title: Interferon for hepatitis C: where it has been and where it is going.
authors.forename: Ronald L
authors.initials: RL
authors.lastname: Koretz
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use; D054316:Biomarkers, Pharmacological / Q000378:metabolism; D015975:Consensus Development Conferences, NIH as Topic; D019317:Evidence-Based Medicine; D016174:Hepacivirus / Q000187:drug effects* / Q000502:physiology; D006526:Hepatitis C / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy / Q000379:methods* / Q000639:trends; D007372:Interferons / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012254:Ribavirin / Q000627:therapeutic use; D016896:Treatment Outcome; D014481:United States
chemical_list: D000998:Antiviral Agents; D054316:Biomarkers, Pharmacological; D012254:Ribavirin; D007372:Interferons